Suppr超能文献

智力残疾儿童血液中谷氨酸和鸟氨酸水平较高。

High levels of blood glutamic acid and ornithine in children with intellectual disability.

作者信息

Wasim Muhammad, Khan Haq Nawaz, Ayesha Hina, Tawab Abdul, Habib Fazal E, Asi Muhammad Rafique, Iqbal Mazhar, Awan Fazli Rabbi

机构信息

Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad, Pakistan.

Pakistan Institute of Engineering and Applied Sciences (PIEAS), Nilore, Pakistan.

出版信息

Int J Dev Disabil. 2020 Dec 21;68(5):609-614. doi: 10.1080/20473869.2020.1858520. eCollection 2022.

Abstract

Aminoacidopathies are inborn errors of metabolism (IEMs) that cause intellectual disability in children. Luckily, aminoacidopathies are potentially treatable, if diagnosed earlier in life. The focus of this study was the screening of aminoacidopathies in a cohort of patients suspected for IEMs. Blood samples from healthy (IQ > 90;  = 391) and intellectually disabled (IQ < 70;  = 409) children (suspected for IEMs) were collected from different areas of Northern Punjab, Pakistan. An analytical HPLC assay was used for the screening of plasma amino acids. All the samples ( = 800) were analyzed on HPLC and forty-three out of 409 patient samples showed abnormal amino acid profiles mainly in the levels of glutamic acid, ornithine and methionine. Plasma concentration (Mean ± SD ng/mL) were significantly high in 40 patients for glutamic acid (patients: 165 ± 38 vs. controls: 57 ± 8,  < 0.00001) and ornithine (patients: 3177 ± 937 vs. controls: 1361 ± 91,  < 0.0001). Moreover, 3 patients showed abnormally high (53.3 ± 8.6 ng/mL) plasma levels of methionine. In conclusion, biochemical analysis of samples from such patients at the metabolites level could reveal the underlying diseases which could be confirmed through advanced biochemical and genetic analyses. Thus, treatment to some of such patients could be offered. Thus burden of intellectual disability caused by such rare metabolic diseases could be reduced from the target populations.

摘要

氨基酸病是导致儿童智力残疾的先天性代谢缺陷病(IEMs)。幸运的是,如果在儿童早期被诊断出来,氨基酸病是有可能得到治疗的。本研究的重点是对一组疑似患有IEMs的患者进行氨基酸病筛查。从巴基斯坦旁遮普省北部不同地区收集了健康儿童(智商>90;n = 391)和智力残疾儿童(智商<70;n = 409)(疑似患有IEMs)的血样。采用分析型高效液相色谱法(HPLC)检测血浆氨基酸。对所有800份样本进行了HPLC分析,409份患者样本中有43份显示氨基酸谱异常,主要表现为谷氨酸、鸟氨酸和蛋氨酸水平异常。40名患者的谷氨酸血浆浓度(平均值±标准差,ng/mL)显著升高(患者:165±38 vs. 对照组:57±8,P<0.00001),鸟氨酸血浆浓度也显著升高(患者:3177±937 vs. 对照组:1361±91,P<0.0001)。此外,3名患者的蛋氨酸血浆水平异常升高(53.3±8.6 ng/mL)。总之,对此类患者样本进行代谢物水平的生化分析可以揭示潜在疾病,这些疾病可通过先进的生化和基因分析得到确诊。因此,可以为其中一些患者提供治疗。这样就可以减轻目标人群中由这种罕见代谢疾病导致的智力残疾负担。

相似文献

1
High levels of blood glutamic acid and ornithine in children with intellectual disability.
Int J Dev Disabil. 2020 Dec 21;68(5):609-614. doi: 10.1080/20473869.2020.1858520. eCollection 2022.
4
Aminoacidopathies: Prevalence, Etiology, Screening, and Treatment Options.
Biochem Genet. 2018 Apr;56(1-2):7-21. doi: 10.1007/s10528-017-9825-6. Epub 2017 Nov 1.
5
Diagnostic challenges of aminoacidopathies and organic acidemias in a developing country: a twelve-year experience.
Clin Biochem. 2013 Dec;46(18):1787-92. doi: 10.1016/j.clinbiochem.2013.08.009. Epub 2013 Aug 28.
7
Treatable inborn errors of metabolism causing intellectual disability: a systematic literature review.
Mol Genet Metab. 2012 Mar;105(3):368-81. doi: 10.1016/j.ymgme.2011.11.191. Epub 2011 Nov 30.
8
Need and Challenges in Establishing Newborn Screening Programs for Inherited Metabolic Disorders in Developing Countries.
Adv Biol (Weinh). 2023 Jul;7(7):e2200318. doi: 10.1002/adbi.202200318. Epub 2023 Apr 5.
9
Screening for organic acidurias and aminoacidopathies in high-risk Brazilian patients: Eleven-year experience of a reference center.
Genet Mol Biol. 2019;42(1 suppl 1):178-185. doi: 10.1590/1678-4685-GMB-2018-0105. Epub 2019 Apr 11.
10
Selective screening for inborn errors of metabolism by tandem mass spectrometry at Sohag University Hospital, Egypt.
Arch Pediatr. 2022 Jan;29(1):36-43. doi: 10.1016/j.arcped.2021.11.002. Epub 2021 Nov 27.

引用本文的文献

1
Consolidated Newborn Bloodspot Screening Efforts in Developing Countries in the Asia Pacific-2024.
Int J Neonatal Screen. 2024 Dec 30;11(1):2. doi: 10.3390/ijns11010002.

本文引用的文献

3
Urea cycle disorders in India: clinical course, biochemical and genetic investigations, and prenatal testing.
Orphanet J Rare Dis. 2018 Oct 1;13(1):174. doi: 10.1186/s13023-018-0908-1.
5
The microbiome and inborn errors of metabolism: Why we should look carefully at their interplay?
Genet Mol Biol. 2018;41(3):515-532. doi: 10.1590/1678-4685-GMB-2017-0235.
6
An Overview of Traditional and Novel Therapeutic Options for the Management of Phenylketonuria.
Crit Rev Eukaryot Gene Expr. 2018;28(2):177-185. doi: 10.1615/CritRevEukaryotGeneExpr.2018023073.
7
A proposed nosology of inborn errors of metabolism.
Genet Med. 2019 Jan;21(1):102-106. doi: 10.1038/s41436-018-0022-8. Epub 2018 Jun 8.
8
Integration of genomics and metabolomics for prioritization of rare disease variants: a 2018 literature review.
J Inherit Metab Dis. 2018 May;41(3):435-445. doi: 10.1007/s10545-018-0139-6. Epub 2018 May 2.
9
Eight novel mutations of CBS gene in nine Chinese patients with classical homocystinuria.
World J Pediatr. 2018 Apr;14(2):197-203. doi: 10.1007/s12519-018-0135-9. Epub 2018 Mar 5.
10
Methionine adenosyltransferase I/III deficiency: beyond the central nervous system manifestations.
Ther Clin Risk Manag. 2018 Feb 2;14:225-229. doi: 10.2147/TCRM.S151732. eCollection 2018.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验